The apolipoprotein E genotype predicts postprandial hypertriglyceridemia in patients with the metabolic syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 5, 2005, Pages 2972-2975

  Cardona, F ^a   Morcillo, S ^a   Gonzalo Marin, M ^a   Tinahones, F J ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; FAT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; URIC ACID;

ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DNA POLYMORPHISM; FAT INTAKE; FEMALE; GENOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AGED; APOLIPOPROTEINS E; FEMALE; GENOTYPE; HUMANS; HYPERTRIGLYCERIDEMIA; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 18844363144     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1912     Document Type: Article

References (26)

1. Rall SC, Weisgraber KH, Mahley RW 1982 Human apolipoprotein E: the complete amino acid sequence. J Biol Chem 257:4171-4178
2. Lahoz C, Schaefer EJ, Cupples LA, Wilson PW, Levy D, Osgood D, Parpos S, Pedro-Botet J, Daly JA, Ordovas JM 2001 Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 154: 529-537
3. Weisgraber KH, Innerarity TL, Mahley RW 1982 Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 257:2518-2521
4. Weintraub MS, Eisenberg S, Breslow JL 1987 Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 80:1571-1577
5. Brown AJ, Roberts DCK 1991 The effect of fasting triglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia. Arterioscler Thromb 11:1737-1744
6. Boerwinkle ES, Brown AR, Sharrett G, Heiss G, Patsh W 1994 Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentration. Am J Hum Genet 54:341-360
7. Mahley RW, Rall SC 1995 Type III hyperlipoproteinemia: the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease, 7th Ed. New York: McGraw Hill; 1953-1980
8. Gregg RE, Zech LA, Schaefer EKJ, Stark D, Wilson D, Brewer HB 1986 Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 78:815-821
9. Dallongeville J, Lussier-Cacan S, Davignon J 1992 Modulation of plasma triglyceride levels by apo E phenotype: a meta-analysis. J Lipid Res 33:447-454
10. Bergeron N, Havel RJ 1996 Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein ε4 allele. J Clin Invest 97:65-72
11. Dallongeville J, Tiret L, Visvikis S, O'Reilly D, Saava JStM, Tsitouris G, Rosseneu M, DeBacker G, Humphries SE, Beisiegel U 1999 Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a family history of myocardial infarction: the EARS II study. Atherosclerosis 145:381-388
12. Dart A, Sherrard B, Simpson H 1997 Influence of apo E phenotype on postprandial triglyceride and glucose responses in subjects with and without coronary heart disease. Atherosclerosis 130:161-170
13. Kobayashi J, Saito Y, Taira K, Hikita M, Takahashi K, Bujo H, Morisaki N, Saito Y 2001 Effect of apolipoprotein E3/4 phenotype on postprandial triglycerides and retinyl palmitate metabolism in plasma from hyperlipidemic subjects in Japan. Atherosclerosis 154:539-546
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). J Am Med Assoc 285:2486-2497
15. Miller SA, Dykes DD, Polesky HF 1988 A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
16. Queipo-Ortuno MI, Garcia-Ordonez MA, Colmenero JD, Morata P 1999 Hydrogen peroxide improves the efficiency of a peripheral blood PCR assay for diagnosis of human brucellosis. Biotechniques 27:248-250
17. Tammi A, Ronnemaa T, Viikari J, Jokinen E, Lapinleimu H, Ehnholm C, Simell O 2000 Apolipoprotein E4 phenotype increases non-fasting serum triglyceride concentration in infants: the STRIP study. Atherosclerosis 152:135-141
18. Srinivasan SR, Ehnholm C, Wattigney WA, Berenson GS 1996 Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period. The Bogalusa Heart Study. Atherosclerosis 127:73-79
19. Salah D, Bohnet K, Gueguen R, Siest G, Visvikis S 1997 Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort. J Lipid Res 38:904-912
20. Reiber I, Mezo I, Kalina A, Palos G, Romics L, Csaszar A 2003 Postprandial triglyceride levels in familial combined hyperlipidemia. The role of apolipoprotein E and lipoprotein lipase polymorphisms. J Nutr Biochem 14:394-400
21. Reznik Y, Morello R, Pousse P, Mahoudeau J, Fradin S 2002 The effect of age, body mass index, and fasting triglyceride level on postprandial lipemia is dependent on apolipoprotein E polymorphism in subjects with non-insulin- dependent diabetes mellitus. Metabolism 51:1088-1092
22. Rensen PN, van Berkel TC 1996A polipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J Biol Chem 271:14791-14799
23. Cardona F, Tinahones FJ, Collantes E, Escudero A, Garcia-Fuentes E, Soriguer FJ 2003 The elevated prevalence of apolipoprotein E2 in patients with gout is associated with reduced renal excretion of urates. Rheumatology 42: 468-472
24. Tinahones FJ, Collantes E, C-Soriguer FJ, Gonzalez-Ruiz A, Pineda M, Anon J, Sanchez Guijo P 1995 Increased VLDL levels and diminished renal excretion of uric acid in hyperuricaemic-hypertriglyceridaemic patients. Br J Rheumatol 34:920-924
25. Tinahones JF, Perez-Lindon G, C-Soriguer FJ, Pareja A, Sanchez-Guijo P, Collantes E 1997 Dietary alterations in plasma very low density lipoprotein levels modify renal excretion of urates in hyperuricemic-hypertriglyceridemic patients. J Clin Endocrinol Metab 82:1188-1191
26. Vázquez-Mellado J, García-García C, Guzmán-Vázquez S, Medrano G, Ornelas M, Alcocer L, Marquez A, Burgos-Vargas R 2004 Metabolic syndrome and ischemic heart disease in gout. J Clin Rheumatlol 10:1-5